What Heraeus Medical does

Heraeus Medical GmbH is a privately held medical device company and division of the family-owned Heraeus Group (Heraeus Holding GmbH), headquartered in Wehrheim, Germany. The company manufactures bone cements, mixing and application systems, pulse lavage systems, and bioresorbable bone substitute materials for orthopaedic and trauma surgery, with end users being orthopaedic surgeons, operating theatre staff, pharmacists, and the hospitals and ambulatory surgical centres in which they practice. Its portfolio is anchored by the PALACOS and COPAL bone cement brands (including antibiotic-loaded variants for infection prevention and management), OSTEOPAL cements for spinal surgery, and complementary handling systems such as PALAMIX, PALABOWL, palaJet, and PALAVAGE. Since 2025 the company has expanded into regenerative orthopaedics via the acquisition of INNOTERE GmbH (Radebeul) and the launch of the heracure brand: heracure one, a ready-to-use calcium phosphate paste in prefilled syringes, and heracure 3D, 3D-printed scaffolds manufactured through a patented process, both built on the proprietary BONEPACE Technology alpha-tricalcium phosphate platform that converts to bone-mineral-like hydroxyapatite in situ.

The company generates revenue primarily through direct B2B sales of medical devices and consumables, with distribution supplemented by a network of 70+ distribution partners reaching over 90 countries across Europe, Asia Pacific, North America, the Middle East, Latin America, and Africa. Pricing is quote-based and not publicly disclosed; the go-to-market combines an enterprise field sales motion targeted at orthopaedic departments and hospital systems with event-driven engagement at major orthopaedic congresses (EBJIS, BOA, DKOU, SOFCOT). Customer education and clinical engagement are delivered through PALACADEMY, an in-house learning platform that has trained over 22,000 healthcare professionals across 53 countries since 2006 via 900+ live and digital events, functioning as a quasi-developer-relations channel for surgeon adoption.

Operationally, the company holds ISO 13485 (DIN EN and MDSAP), ISO 14001, and ISO 45001 certifications, has secured EU MDR certification for the heracure line, COPAL G+V, PALACOS (without gentamicin), and PALAMIX during 2025-2026, and has achieved EcoVadis Gold status (top 5%) for two consecutive years. Heraeus Medical does not publicly disclose standalone revenue and is currently navigating the recovery from a 2025 packaging-related production halt at its main site, with first product releases from resumed pouch bone cement production expected from mid-July 2026. The US market is explicitly excluded from the current commercial footprint.

Name

Heraeus Medical

Legal name

Heraeus Medical GmbH

Website

https://heraeus-medical.com

Company type

Private

Founded year

1851

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Heraeus Medical GmbH is a Wehrheim, Germany-based medical device company (division of Heraeus Group) that manufactures bone cements, mixing and lavage systems, and bioresorbable bone substitute materials for orthopaedic and trauma surgeons across more than 90 countries.

Ownership category

akta.pro rank

Product category

Orthopedic Medical Devices

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)

akta.pro secondary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

Keywords

• Orthopedic bone cements
• Surgical biomaterials
• Joint arthroplasty devices
• Bone regeneration materials
• Medical mixing systems

Headquarters

HQ city

Yardley

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Medical Device and Biomaterial Sales: Heraeus Medical generates revenue through the sale of medical devices including bone cements, biomaterials, mixing systems, and accessories for orthopaedic and trauma surgery. Products are sold directly or through distribution partners in over 90 countries.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Core offering

Heraeus Medical manufactures orthopedic bone cements under the PALACOS, COPAL, and OSTEOPAL brands for implant fixation in joint replacement and spinal surgery, antibiotic-loaded cements for infection prevention, and complementary mixing and pulse lavage systems (PALAMIX, PALABOWL, palaJet, PALAVAGE). The company also sells bioresorbable bone substitute materials (heracure one paste and heracure 3D printed scaffolds) for regenerative orthopedics, supported by the PALACADEMY education platform for healthcare professionals.

Product overview

Heraeus Medical is a leader in bone cements and biomaterials for surgical orthopaedics and trauma surgery. The product portfolio centers on bone cements (PALACOS, COPAL, OSTEOPAL brands) for implant fixation in joint replacement surgery, with complementary mixing and lavage accessories (PALAMIX, PALABOWL, palaJet, PALAVAGE). The recently launched heracure line (heracure one, heracure 3D) expands into resorbable biomaterials for regenerative orthopedics following the 2025 acquisition of INNOTERE GmbH. The PALACADEMY educational platform provides training and resources for healthcare professionals. All products focus on improving surgical outcomes in bone and joint surgery, infection management, and bone regeneration.

Differentiator

Problem solved

Functional benefit

Brands

• PALACOS: Bone cements for implant fixation and infection prevention
• COPAL
• OSTEOPAL
• heracure
• PALAMIX
• PALABOWL
• palaJet
• PALAVAGE
• PALACADEMY
• pro All-In-One Fixation System

Products and services

• PALACOS bone cements
• COPAL bone cements
• OSTEOPAL bone cements
• heracure one
• heracure 3D
• PALAMIX
• PALABOWL
• palaJet
• palaJet AC
• PALAVAGE
• pro All-In-One Fixation System
• PALACADEMY

Quantifiable outcome

• Over 22,000 healthcare professionals trained through PALACADEMY education programs
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• INNOTERE GmbHcoreStrategic or Co-development Partner · 1 January 2025INNOTERE GmbH, based in Radebeul, Germany, was acquired by Heraeus Medical in 2025. The company develops and manufactures innovative calcium phosphate-based biomaterials for bone regeneration. The integration began at the start of 2025 and was completed in the last months of 2025. INNOTERE will continue to operate from its Radebeul location and brings highly skilled experts with extensive know-how in resorbable biomaterials.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Zimmer Biomet: Global orthopedic medical device leader with deep presence in joint reconstruction implants (hip, knee, shoulder) where Heraeus Medical's PALACOS bone cements are commonly used. Direct adjacency through cement usage in their primary implant portfolio makes them the closest comparable broad incumbent.
• DJO (Enovis): Orthopedic and recovery sciences company (now part of Enovis) with joint reconstruction and surgical implant offerings. Comparable as an orthopedic incumbent addressing similar hospital and surgical center customers with adjacent product categories.
• DePuy Synthes (Johnson & Johnson MedTech): Johnson & Johnson's orthopedic arm covering joint reconstruction, trauma, and spine. Comparable as a broad incumbent that addresses the same end-customers (orthopedic surgeons) and overlapping procedure types where bone cements and bone substitutes are utilized.
• Medtronic (Spine & Biologics): Diversified medical technology leader with significant spinal surgery and bone biologics franchises. Comparable as a broad incumbent competing in spinal bone cement (OSTEOPAL) and orthobiologics (heracure) market segments.
• Stryker: Major diversified orthopedic medical device company with significant joint reconstruction and trauma businesses that consume bone cements and biologics. Comparable as a full-spectrum orthopedic incumbent competing for the same hospital procurement budgets.
• Smith+Nephew: UK-headquartered orthopedic and wound care company with established hip and knee reconstruction portfolios. Direct overlap with Heraeus Medical in joint replacement supply chain and hospital channel relationships across Europe and globally.

Direct peers

• B. Braun Melsungen: German medical device company that directly competes in bone cements and orthopedic surgical supplies with the Aesculap division. Most direct head-to-head competitor with Heraeus Medical in PMMA bone cements for joint arthroplasty in European markets.
• Exactech: Orthopedic device company focused on joint replacement implants and bone cement products. Directly comparable as a mid-sized orthopedic player with bone cement offerings competing for the same hospital arthroplasty accounts.
• Teknimed: France-based specialty manufacturer focused on bone cements, bone substitutes, and surgical adhesives for orthopedic applications. Closely comparable as a focused bone cement and biomaterial specialist with overlapping surgeon customer base.
• Orthofix Medical: Orthopedic and spine medical device company with bone graft substitute and biologic offerings. Comparable as a peer operating in adjacent bone regeneration and spinal surgery categories where Heraeus Medical's OSTEOPAL and heracure compete.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/heraeus
• LinkedInlinkedin.com/company/heraeus-medical
• Xx.com/HeraeusMedical
• Facebookfacebook.com/HeraeusMedicalUSA

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Heraeus Medical